Journal of Clinical Medicine (Jun 2024)

Upper Airway Alarmin Cytokine Expression in Asthma of Different Severities

  • Hazel Marriott,
  • Marc Duchesne,
  • Subhabrata Moitra,
  • Isobel Okoye,
  • Luke Gerla,
  • Irvin Mayers,
  • Jalal Moolji,
  • Adil Adatia,
  • Paige Lacy

DOI
https://doi.org/10.3390/jcm13133721
Journal volume & issue
Vol. 13, no. 13
p. 3721

Abstract

Read online

Background: The secretion of alarmin cytokines by epithelial cells, including thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33, initiates inflammatory cascades in asthma. However, alarmin cytokine expression in the upper airways in asthma remains largely unknown. Methods: We recruited 40 participants with asthma into four groups as per the Global Initiative for Asthma (GINA) steps (10 in each group of GINA 1/2, 3, 4, and 5). Cells were derived from nasal, buccal, and throat brushings. Intracellular cytokine expression (TSLP, IL-25, and IL-33) was assessed by flow cytometry in cytokeratin 8+ (Ck8+) epithelial cells immediately following collection. Results: TSLP was significantly increased (p + epithelial cells, while IL-25 was elevated in nasal and throat samples (p p = 0.03) elevated but did not differ between patients with and without nasal comorbidities. IL-25 and IL-33 (obtained from nasal, buccal, and throat samples) were not significantly different in individual groups. Conclusions: Our study demonstrates for the first time that Ck8+ nasal epithelial cells from GINA 5 asthma patients express elevated levels of TSLP.

Keywords